Authors:
Mateo, MS
Mollejo, M
Villuendas, R
Algara, P
Sanchez-Beato, M
Martinez, P
Piris, MA
Citation: Ms. Mateo et al., Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5 ' non-coding region of the bcl-6 gene, LEUKEMIA, 15(4), 2001, pp. 628-634
Authors:
Casado, LF
Granados, E
Algara, P
Navarro, F
Martinez-Frejo, MD
Lopez-Botet, M
Citation: Lf. Casado et al., High expression of the ILT2 (LIR-1) inhibitory receptor for major histocompatibility complex class I molecules on clonal expansions of T-large granular lymphocytes in asymptomatic patients, HAEMATOLOG, 86(5), 2001, pp. 457-463
Authors:
Fernandez-Vazquez, A
Rodriguez-Peralto, JL
Martinez, MA
Platon, EM
Algara, P
Camacho, FI
Lopez-Rios, F
Zarco, C
Sanchez-Yus, E
Fresno, MF
Barthe, L
Aliaga, A
Fraga, M
Forteza, J
Oliva, H
Piris, MA
Citation: A. Fernandez-vazquez et al., Primary cutaneous large B-cell lymphoma - The relation between morphology,clinical presentation, immunohistochemical markers, and survival, AM J SURG P, 25(3), 2001, pp. 307-315
Authors:
Camacho, FI
Mollejo, M
Mateo, MS
Algara, P
Navas, C
Hernandez, JM
Santoja, C
Sole, F
Sanchez-Beato, M
Piris, MA
Citation: Fi. Camacho et al., Progression to large B-cell lymphoma in splenic marginal zone lymphoma - Adescription of a series of 12 cases, AM J SURG P, 25(10), 2001, pp. 1268-1276
Authors:
Sanchez-Beato, M
Saez, AI
Navas, IC
Algara, P
Mateo, MS
Villuendas, R
Camacho, F
Sanchez-Aguilera, A
Sanchez, E
Piris, MA
Citation: M. Sanchez-beato et al., Overall survival in aggressive B-Cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27, AM J PATH, 159(1), 2001, pp. 205-213
Authors:
Lloret, E
Mollejo, M
Mateo, MS
Villuendas, R
Algara, P
Martinez, P
Piris, MA
Citation: E. Lloret et al., Splenic marginal zone lymphoma with increased number of blasts: An aggressive variant?, HUMAN PATH, 30(10), 1999, pp. 1153-1160
Authors:
Tutor-Ureta, O
Diaz, MA
Algara, P
Madero, L
Martinez, P
Citation: O. Tutor-ureta et al., Minimal residual disease in induction therapy is a predictive factor of relapse in standard risk childhood B-precursor acute lymphoblastic leukaemia, MED CLIN, 113(4), 1999, pp. 129-131
Authors:
Garcia, JF
Villuendas, R
Algara, P
Saez, AI
Sanchez-Verde, L
Martinez-Montero, JC
Martinez, P
Piris, MA
Citation: Jf. Garcia et al., Loss of p16 protein expression associated with methylation of the p16(INK4A) gene is a frequent finding in Hodgkin's disease, LAB INV, 79(12), 1999, pp. 1453-1459